Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)

Clinical trial NCT06337162 · WITHDRAWN

Trial details

NCT number: NCT06337162
Sponsor: Abramson Cancer Center at Penn Medicine
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2024-05-01
Primary completion: 2027-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.